Cargando…

ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway

BACKGROUND: Inflammation plays a major role in the pulmonary artery hypertension (PAH) and the acute lung injury (ALI) diseases. The common feature of these complications is the dysfunction of pulmonary microvascular endothelial cells (PMVECs). Fasudil, the only Rho kinase (ROCK) inhibitor used in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Huanlong, Pan, Zhenhua, Ma, Xindi, Cui, Junru, Gao, Juan, Miao, Qingfeng, Zhu, Zhongning, Chen, Xueyan, Su, Suwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013060/
https://www.ncbi.nlm.nih.gov/pubmed/35428330
http://dx.doi.org/10.1186/s40360-022-00565-7
_version_ 1784687919672328192
author Liu, Huanlong
Pan, Zhenhua
Ma, Xindi
Cui, Junru
Gao, Juan
Miao, Qingfeng
Zhu, Zhongning
Chen, Xueyan
Su, Suwen
author_facet Liu, Huanlong
Pan, Zhenhua
Ma, Xindi
Cui, Junru
Gao, Juan
Miao, Qingfeng
Zhu, Zhongning
Chen, Xueyan
Su, Suwen
author_sort Liu, Huanlong
collection PubMed
description BACKGROUND: Inflammation plays a major role in the pulmonary artery hypertension (PAH) and the acute lung injury (ALI) diseases. The common feature of these complications is the dysfunction of pulmonary microvascular endothelial cells (PMVECs). Fasudil, the only Rho kinase (ROCK) inhibitor used in clinic, has been proved to be the most promising new drug for the treatment of PAH, with some anti-inflammatory activity. Therefore, in the present study, the effect of fasudil on lipopolysaccharide (LPS)-induced inflammatory injury in rat PMVECs was investigated. METHODS: LPS was used to make inflammatory injury model of rat PMVECs. Thereafter, the mRNA and protein expression of pro-inflammatory factors was evaluated by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) assay respectively. Intracellular reactive oxygen species (ROS) levels were measured by the confocal laser scanning system. The activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and the content of malondialdehyde (MDA) were determined by using commercial kits according to the manufacturer’s instructions. Western blot assay was used to detect the protein expression of nuclear factor kappa B (NF-κB) p65. RESULTS: Fasudil effectively prevented inflammatory injury induced by LPS, which is manifested by the decrease of pro-inflammatory cytokines interleukin-6 (IL-6) and monocyte chenotactic protein-1 (MCP-1). Meanwhile, fasudil dramatically reduced the levels of ROS and MDA, and also elevated the activities of SOD and GSH-Px. Furthermore, the nuclear translocation of NF-κB p65 induced by LPS was also suppressed by fasudil. Additionally, the ROS scavengers N-Acetylcysteine (N-Ace) was also found to inhibit the nuclear translocation of NF-κB and the mRNA expression of IL-6 and MCP-1 induced by LPS, which suggested that ROS was essential for the nuclear translocation of NF-κB. CONCLUSIONS: The present study revealed that fasudil reduced the expression of inflammatory factors, alleviated the inflammatory and oxidative damage induced by LPS in rat PMVECs via ROS-NF-κB signaling pathway.
format Online
Article
Text
id pubmed-9013060
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90130602022-04-17 ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway Liu, Huanlong Pan, Zhenhua Ma, Xindi Cui, Junru Gao, Juan Miao, Qingfeng Zhu, Zhongning Chen, Xueyan Su, Suwen BMC Pharmacol Toxicol Research BACKGROUND: Inflammation plays a major role in the pulmonary artery hypertension (PAH) and the acute lung injury (ALI) diseases. The common feature of these complications is the dysfunction of pulmonary microvascular endothelial cells (PMVECs). Fasudil, the only Rho kinase (ROCK) inhibitor used in clinic, has been proved to be the most promising new drug for the treatment of PAH, with some anti-inflammatory activity. Therefore, in the present study, the effect of fasudil on lipopolysaccharide (LPS)-induced inflammatory injury in rat PMVECs was investigated. METHODS: LPS was used to make inflammatory injury model of rat PMVECs. Thereafter, the mRNA and protein expression of pro-inflammatory factors was evaluated by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) assay respectively. Intracellular reactive oxygen species (ROS) levels were measured by the confocal laser scanning system. The activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and the content of malondialdehyde (MDA) were determined by using commercial kits according to the manufacturer’s instructions. Western blot assay was used to detect the protein expression of nuclear factor kappa B (NF-κB) p65. RESULTS: Fasudil effectively prevented inflammatory injury induced by LPS, which is manifested by the decrease of pro-inflammatory cytokines interleukin-6 (IL-6) and monocyte chenotactic protein-1 (MCP-1). Meanwhile, fasudil dramatically reduced the levels of ROS and MDA, and also elevated the activities of SOD and GSH-Px. Furthermore, the nuclear translocation of NF-κB p65 induced by LPS was also suppressed by fasudil. Additionally, the ROS scavengers N-Acetylcysteine (N-Ace) was also found to inhibit the nuclear translocation of NF-κB and the mRNA expression of IL-6 and MCP-1 induced by LPS, which suggested that ROS was essential for the nuclear translocation of NF-κB. CONCLUSIONS: The present study revealed that fasudil reduced the expression of inflammatory factors, alleviated the inflammatory and oxidative damage induced by LPS in rat PMVECs via ROS-NF-κB signaling pathway. BioMed Central 2022-04-15 /pmc/articles/PMC9013060/ /pubmed/35428330 http://dx.doi.org/10.1186/s40360-022-00565-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Huanlong
Pan, Zhenhua
Ma, Xindi
Cui, Junru
Gao, Juan
Miao, Qingfeng
Zhu, Zhongning
Chen, Xueyan
Su, Suwen
ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway
title ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway
title_full ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway
title_fullStr ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway
title_full_unstemmed ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway
title_short ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway
title_sort rock inhibitor fasudil reduces the expression of inflammatory factors in lps-induced rat pulmonary microvascular endothelial cells via ros/nf-κb pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013060/
https://www.ncbi.nlm.nih.gov/pubmed/35428330
http://dx.doi.org/10.1186/s40360-022-00565-7
work_keys_str_mv AT liuhuanlong rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway
AT panzhenhua rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway
AT maxindi rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway
AT cuijunru rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway
AT gaojuan rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway
AT miaoqingfeng rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway
AT zhuzhongning rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway
AT chenxueyan rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway
AT susuwen rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway